ValiRx PLC (LSE:VAL) - Share price


Stock Report

ValiRx PLC VAL

Last Price
GBX0.17

Day Change
0.00|-2.86%

As of 16/08/2019
16:24:23 BST | GBX
Minimum 15 Minutes Delay.

Last Close0.18p
Day Range0.16 - 0.18
Mkt Cap1.74Mil
52-Wk Range0.13 - 2.75
Yield %-
ISINGB00BWWYSP41
Volume6,884,271
P/E-0.20
P/SInfinity
P/CF0.00

Share Price

Total Returns 16/08/2019

 Chg (%)  
More ...
ValiRx PLC0.00 
FTSE 100 TR GBP-5.20
 
Financials
201620172018
More ...
Income Statement
Turnover-0.000.00
Operating Profit-4.17-3.13-4.37
Net Profit-5.13-3.14-4.37
Reported EPS-8.54-1.90-0.94
Balance Sheet
Current Assets2.132.011.01
Non Current Assets2.842.933.23
Total Assets4.964.944.24
Current Liabilities2.591.781.20
Total Liabilities---
Total Equity2.373.153.03
Cash Flow
Operating Cash Flow-4.57-2.99-3.78
Net Change in Cash0.330.14-0.33
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
31/12/2018PurchaseDr. George Morris7.501,333,333100,000.00
31/12/2018PurchaseDr. Satu Vainikka7.501,333,333100,000.00
31/12/2018PurchaseMr. Gerald Desler7.501,333,333100,000.00
31/12/2018PurchaseOliver de Giorgio-Miller7.501,333,333100,000.00

Company Profile

ValiRx PLC is a biopharmaceutical company. It is engaged in developing technologies and products in oncology therapeutics and diagnostics focused on the treatment of cancer and associated Biomarkers, specializing in epigenomic and genetic analysis.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 25/09/2019

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-159.30
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Operating OfficerDr. George Morris
Executive Director, Chief Executive OfficerDr. Satu Vainikka
Executive Director, Finance DirectorMr. Gerald Desler
Non-Executive Director, Company SecretaryMr. Kevin J Alexander
Non-Executive Director, ChairmanOliver de Giorgio-Miller
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.